Immunotherapies Stocks List

Recent Signals

Date Stock Signal Type
2021-09-17 ADAG Lower Bollinger Band Walk Weakness
2021-09-17 ADAG Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-09-17 ADXS 1,2,3 Pullback Bullish Bullish Swing Setup
2021-09-17 ADXS Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-09-17 ADXS Calm After Storm Range Contraction
2021-09-17 ADXS NR7 Range Contraction
2021-09-17 ALPN Bollinger Band Squeeze Range Contraction
2021-09-17 ALPN Upper Bollinger Band Walk Strength
2021-09-17 ALPN Pocket Pivot Bullish Swing Setup
2021-09-17 ALPN Calm After Storm Range Contraction
2021-09-17 ALPN Slingshot Bullish Bullish Swing Setup
2021-09-17 ALPN Stochastic Reached Overbought Strength
2021-09-17 BLCM Crossed Above 20 DMA Bullish
2021-09-17 BLCM Stochastic Buy Signal Bullish
2021-09-17 BLCM Crossed Above 50 DMA Bullish
2021-09-17 CMPI Narrow Range Bar Range Contraction
2021-09-17 CMPI Calm After Storm Range Contraction
2021-09-17 GMAB Slingshot Bearish Bearish Swing Setup
2021-09-17 GMAB Stochastic Buy Signal Bullish
2021-09-17 GMAB Pocket Pivot Bullish Swing Setup
2021-09-17 GOVX Narrow Range Bar Range Contraction
2021-09-17 GOVX Stochastic Buy Signal Bullish
2021-09-17 GOVX NR7 Range Contraction
2021-09-17 GRTS Wide Range Bar Range Expansion
2021-09-17 GRTS Slingshot Bullish Bullish Swing Setup
2021-09-17 GRTS Bearish Engulfing Bearish
2021-09-17 GRTS Volume Surge Other
2021-09-17 HCWB New 52 Week Low Weakness
2021-09-17 HCWB New 52 Week Closing Low Bearish
2021-09-17 HCWB Stochastic Reached Oversold Weakness
2021-09-17 IMCR Crossed Above 50 DMA Bullish
2021-09-17 IMCR 20 DMA Support Bullish
2021-09-17 IMTX Calm After Storm Range Contraction
2021-09-17 IMV 20 DMA Support Bullish
2021-09-17 IMV 50 DMA Support Bullish
2021-09-17 MRKR Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-09-17 MRKR Bollinger Band Squeeze Range Contraction
2021-09-17 NBTX NR7 Range Contraction
2021-09-17 NBTX Narrow Range Bar Range Contraction
2021-09-17 NEXI Wide Range Bar Range Expansion
2021-09-17 NEXI Shooting Star Candlestick Bearish
2021-09-17 NEXI Doji - Bearish? Reversal
2021-09-17 NEXI New Uptrend Bullish
2021-09-17 NEXI Upper Bollinger Band Walk Strength
2021-09-17 NEXI Calm After Storm Range Contraction
2021-09-17 NEXI Pocket Pivot Bullish Swing Setup
2021-09-17 NEXI Volume Surge Other
2021-09-17 ONCR Stochastic Reached Oversold Weakness
2021-09-17 ONCR Volume Surge Other
2021-09-17 ONCR Bollinger Band Squeeze Range Contraction
2021-09-17 ONCR New 52 Week Closing Low Bearish
2021-09-17 PDSB Boomer Buy Setup Bullish Swing Setup
2021-09-17 PDSB NR7 Range Contraction
2021-09-17 RCUS Pocket Pivot Bullish Swing Setup
2021-09-17 RCUS Volume Surge Other
2021-09-17 SLS Upper Bollinger Band Walk Strength
2021-09-17 STAB Doji - Bullish? Reversal
2021-09-17 SURF Pocket Pivot Bullish Swing Setup
2021-09-17 SURF MACD Bullish Signal Line Cross Bullish
2021-09-17 SURF MACD Bullish Centerline Cross Bullish
2021-09-17 SURF Expansion Breakout Bullish Swing Setup
2021-09-17 SURF Stochastic Buy Signal Bullish
2021-09-17 SURF Wide Range Bar Range Expansion
2021-09-17 SURF Volume Surge Other
2021-09-17 SURF Crossed Above 50 DMA Bullish
2021-09-17 SURF Crossed Above 20 DMA Bullish
2021-09-17 SURF Expansion Pivot Buy Setup Bullish Swing Setup

Immunotherapies Stocks Recent News

Date Stock Title
Sep 17 SURF Surface Oncology climbs as AstraZeneca cancer trial data highlights anti-CD73 effect
Sep 17 BLCM Bellicum Pharmaceuticals (BLCM ) Investor Presentation - Slideshow
Sep 17 ADAG Hedge Funds are Selling These 10 Chinese Stocks Amid Crackdowns
Sep 17 RCUS AstraZeneca lung cancer data propel Corvus and Arcus
Sep 17 GMAB Analysts Are Downgrading These 10 Stocks
Sep 17 GRTS Dosing underway in Gritstone's Phase 2 SLATE v2 trial in patients with solid tumors
Sep 17 NBTX The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold
Sep 17 GRTS The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold
Sep 17 SURF 15 Stocks Moving in Friday's Pre-Market Session
Sep 17 GRTS Gritstone Announces Dosing of First Solid Tumor Patient with Optimized SLATE “Off-the-Shelf” Mutant KRAS-directed Neoantigen Immunotherapy in Phase 2 Clinical Trial
Sep 17 GRTS Gritstone Announces Positive Clinical Data with GRANITE (Individualized Neoantigen Immunotherapy Program) during ESMO 2021 and Launch of Randomized Clinical Trial Program in Colorectal Cancer with Registrational Intent
Sep 17 GRTS 5 Stocks To Watch For September 17, 2021
Sep 16 GRTS ABCL, TCRR, KYMR and GRTS among after hours movers
Sep 16 GRTS Gritstone bio raises $55M through private placement financing
Sep 16 GRTS Gritstone Announces Private Placement Financing of $55.0 Million
Sep 16 GRTS 3 Explosive Biotech Stocks That Could 10X in 10 Years
Sep 15 ALPN Alpine Immune secures $91M through equity offering
Sep 15 PDSB PDS Biotech Reports An Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Sep 15 ALPN Alpine Immune Sciences Announces $91 Million Private Placement
Sep 14 CMPI Checkmate Pharmaceuticals to Present at the Cantor Virtual Global Healthcare Conference

Immunotherapy is the treatment of disease by activating or suppressing the immune system. Immunotherapies designed to elicit or amplify an immune response are classified as activation immunotherapies, while immunotherapies that reduce or suppress are classified as suppression immunotherapies.

In recent years, immunotherapy has become of great interest to researchers, clinicians and pharmaceutical companies, particularly in its promise to treat various forms of cancer.Immunomodulatory regimens often have fewer side effects than existing drugs, including less potential for creating resistance when treating microbial disease.Cell-based immunotherapies are effective for some cancers. Immune effector cells such as lymphocytes, macrophages, dendritic cells, natural killer cells (NK Cell), cytotoxic T lymphocytes (CTL), etc., work together to defend the body against cancer by targeting abnormal antigens expressed on the surface of tumor cells.
Therapies such as granulocyte colony-stimulating factor (G-CSF), interferons, imiquimod and cellular membrane fractions from bacteria are licensed for medical use. Others including IL-2, IL-7, IL-12, various chemokines, synthetic cytosine phosphate-guanosine (CpG) oligodeoxynucleotides and glucans are involved in clinical and preclinical studies.

More about Immunotherapies
Browse All Tags